The June 20 news article “Large Alzheimer’s study hits a recruitment roadblock” highlighted the difficulty of recruiting candidates for Alzheimer’s clinical trials, a critical factor in finding a cure.
The issue is even more pressing for African Americans, who are two to three times more likely to develop Alzheimer’s than white Americans. Research shows minorities in the United States live sicker and die younger but are more reluctant to participate in clinical research. African Americans make up more than 13 percent of the population but only 5 percent of clinical trials participants. That percentage is even lower for older African Americans.